Skip to main content

  • MAPT (Mono Antiplatelet Therapy) as Regular Regimen After COBRA PzF™ NanoCoated Coronary Stent (NCS) Implantation

    • Posted: 08/11/2020
    • Author:

      Luc Maillard, François Vochelet, Patrick Peycher, Anis Ayari, ... Alain Tavildari

    • CRM2020

    Abstract

    Aims

    To report procedural and 1-year outcomes following COBRA PzF NCS implantation in a routine daily setting with high bleeding risk (HBR) patients treated with clopidogrel as mono antiplatelet therapy (MAPT).

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details